Nakul Pasricha

ASPA Strategic Plan 2022-2027 outlines six goals

Nakul Pasricha, President, ASPA, explains the need for QR codes in curbing the circulation of spurious and substandard medicines…

The report highlights the trends in pharma crime and incidents of sub-standard and falsified (SF) medical products during COVID-19…

Nakul Pasricha, President, ASPA, explains how a timely step taken by the government of India can impact the supply chain to make…

Nakul Pasricha, President, Authentication Solution Providers’ Association (ASPA), emphasises on the need for budget allocation to…

In a recent development, the GST Council reduced the rates of COVID essentials, including drugs for treatment and other related…

A continued immersive awareness and education programme is crucial for healthcare workers so that they can be vigilant towards the…

On the eve of Union Budget 2021, Nakul Pasricha, President of ASPA highlights that along with improving the existing healthcare…

Globally, incidents of fake, counterfeiting pharma products are on the rise and recent cyber attacks on some pharma companies…

Incident of counterfeit cases in India have increased by nearly 15 per cent in 2019. Currency, Liquor, FMCG (F&B) and pharma…